Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other Working Capital Changes (2017 - 2025)

Acro Biomedical has reported Other Working Capital Changes over the past 9 years, most recently at $10000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $10000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $10000.0 (up 900.0% YoY), and the annual figure for FY2025 was $10000.0, up 900.0%.
  • Other Working Capital Changes for Q4 2025 was $10000.0 at Acro Biomedical, up from -$35000.0 in the prior quarter.
  • Over the last five years, Other Working Capital Changes for ACBM hit a ceiling of $35000.0 in Q2 2025 and a floor of -$35000.0 in Q3 2025.
  • Median Other Working Capital Changes over the past 5 years was -$2402.5 (2022), compared with a mean of $541.62.
  • Peak annual rise in Other Working Capital Changes hit 200.15% in 2022, while the deepest fall reached 201.57% in 2022.
  • Acro Biomedical's Other Working Capital Changes stood at $3500.0 in 2021, then plummeted by 201.57% to -$3555.0 in 2022, then fell by 5.49% to -$3750.0 in 2023, then surged by 66.67% to -$1250.0 in 2024, then skyrocketed by 900.0% to $10000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $10000.0 (Q4 2025), -$35000.0 (Q3 2025), and $35000.0 (Q2 2025) per Business Quant data.